TFF Pharmaceuticals Inc. - TFFP Enterprise Value to Sales Volume

Does TFF Pharmaceuticals (TFFP) have a future now that the business liquidation is nearly complete? Optimism was driven by US-based CMO outsourcing sites developing inhalation drugs, but the EV-to-revenue multiple indicates a dangerous overvaluation. The value of captures the metric level amid risks of technological substitution and the slow adoption of freeze-drying by partners, which is crashing the capitalization.
TFF Pharmaceuticals Inc. - analytical breakdowns and key metrics (TFFP)

The EV/Sales metric determines the total enterprise value, including debt, per unit of revenue, allowing for an assessment of the market premium paid for the generated cash flow. By analyzing historical EV/Sales levels, an investor can correlate the valuation of TFF Pharmaceuticals (TFFP) with the potential of its innovative technology for converting drugs into powder form for inhalation, which expands partnerships with global pharma behemoths.